Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Silybin × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Thoracic 1 Genitourinary 1 Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Carboplatin 994 Cisplatin 780 Pemetrexed 718 pembrolizumab 529 Paclitaxel 511 Docetaxel 465 Gemcitabine 361 Radiotherapy 345 Erlotinib Hydrochloride 329 Bevacizumab 292 Nivolumab 288 Etoposide 252 durvalumab 232 Drug Therapy 214 osimertinib 202 atezolizumab 191 Radiosurgery 165 Gefitinib 161 Vinorelbine 134 Magnetic Resonance Spectroscopy 118 130-nm albumin-bound paclitaxel 108 Ipilimumab 105 Cetuximab 97 Topotecan 91 Surgical Procedures, Operative 90 Cyclophosphamide 89 Specimen Handling 87 tislelizumab 84 Irinotecan 83 Blood Specimen Collection 83

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05689619 2023-12-15

SILMET

A.O.U. Città della Salute e della Scienza

Phase NA Recruiting

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡